Skip to main content

Table 1 A brief study schedule at every visit

From: Influence of the Chungkookjang on histamine-induced wheal and flare skin response: a randomized, double-blind, placebo controlled trial

 

Screening Visit 1

Baseline Visit 2

Visit 3

Visit 4

Visit 5

Follow up (Visit 6)

 

D-21 ~D-1

Week 0 D0

Week 4 D28

Week 8 D56

Week 12 D84

Week 16 D112

Informed consent form

â—¯

     

Demographic information taking 1

â—¯

     

Medical history taking

â—¯

     

Inclusion/exclusion criteria check

â—¯

â—¯

    

Physician examination 2

â—¯

   

â—¯

 

Drinking/smoking taking status 3

â—¯

   

â—¯

 

Vital sign measurement

â—¯

â—¯

â—¯

â—¯

â—¯

 

Concomitant drugs check

â—¯

â—¯

â—¯

â—¯

â—¯

 

Electrocardiogram(ECG)

â—¯

   

â—¯

 

Histamine skin prick test

â—¯

   

â—¯

 

Laboratory test 4

â—¯

   

â—¯

 

Histamine & ECP

 

â—¯

  

â—¯

 

Study product distribution

 

â—¯

â—¯

â—¯

  

Compliance checking

  

â—¯

â—¯

â—¯

 

Adverse event monitoring

  

â—¯

â—¯

â—¯

â—¯

Diet, physical exercise counseling 5

 

â—¯

â—¯

â—¯

  
  1. â—¯ : Item need to be performed during the visit
  2. 1 Sex, date of birth, age, contact address and phone number
  3. 2 Include present illness, past history taking
  4. 3,5 Risk factors such as alcohol drinking, smoking, severe exercise and other dietary supplement intake will be managed
  5. 4 Blood test(WBC, RBC, hemoglobin, hematocrit, platelets count, AST, ALT, ALP, gamma-GTP, albumin, BUN, creatinine, glucose, total bilirubin, total protein, total-cholesterol, triglyceride, LDL-C, HDL-C, IgE), urine test(specific gravity, pH, Protein, Ketone, Glucose, bilirubin, urobilinogen, nitrite, microscopic (RBC, WBC))